Act Capital Management 13F annual report
Act Capital Management is an investment fund managing more than $72.5 million ran by Fayth Ecker. There are currently 70 companies in Ecker’s portfolio. The largest investments include Staar Surgical Co and Exxon Mobil, together worth $22.8 million.
$72.5 million Assets Under Management (AUM)
As of 27th October 2022, Act Capital Management’s top holding is 222,800 shares of Staar Surgical Co currently worth over $15.7 million and making up 21.7% of the portfolio value.
Relative to the number of outstanding shares of Staar Surgical Co, Act Capital Management owns more than approximately 0.1% of the company.
In addition, the fund holds 81,600 shares of Exxon Mobil worth $7.12 million, whose value grew 26.9% in the past six months.
The third-largest holding is Devon worth $4.96 million and the next is Krystal Biotech Inc worth $4.06 million, with 58,300 shares owned.
Currently, Act Capital Management's portfolio is worth at least $72.5 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Act Capital Management
The Act Capital Management office and employees reside in Wayne, Pennsylvania. According to the last 13-F report filed with the SEC, Fayth Ecker serves as the Chief Compliance Officer at Act Capital Management.
Recent trades
In the most recent 13F filing, Act Capital Management revealed that it had opened a new position in
Axsome Therapeutics Inc and bought 73,000 shares worth $3.26 million.
This means they effectively own approximately 0.1% of the company.
Axsome Therapeutics Inc makes up
8.6%
of the fund's Health Care sector allocation and has grown its share price by 19.0% in the past year.
The investment fund also strengthened its position in Exxon Mobil by buying
24,700 additional shares.
This makes their stake in Exxon Mobil total 81,600 shares worth $7.12 million.
Exxon Mobil soared 75.1% in the past year.
On the other hand, there are companies that Act Capital Management is getting rid of from its portfolio.
Act Capital Management closed its position in ADTRAN Inc on 3rd November 2022.
It sold the previously owned 150,000 shares for $2.63 million.
Fayth Ecker also disclosed a decreased stake in Staar Surgical Co by approximately 0.1%.
This leaves the value of the investment at $15.7 million and 222,800 shares.
One of the smallest hedge funds
The two most similar investment funds to Act Capital Management are Krs Capital Management and Options Solutions. They manage $72.5 million and $72.6 million respectively.
Fayth Ecker investment strategy
Act Capital Management’s portfolio is diversified across 6 sectors.
Currently, their heaviest sector is Health Care — making up 52.5% of
the total portfolio value.
The fund focuses on investments in the United States as
65.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
27% of the total holdings value.
On the other hand, large-cap stocks make up 10.0% of the portfolio.
The average market cap of the portfolio companies is close to $19.5 billion.
The complete list of Act Capital Management trades based on 13F SEC filings
These positions were updated on November 3rd based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Staar Surgical Co. |
2.66%
222,800
|
$15,719,000 | 21.69% |
| Exxon Mobil Corp. |
43.41%
81,600
|
$7,124,000 | 9.83% |
| Devon Energy Corp. |
No change
82,500
|
$4,961,000 | 6.85% |
| Krystal Biotech Inc |
1.19%
58,300
|
$4,064,000 | 5.61% |
| Arrowhead Pharmaceuticals Inc. |
18.15%
110,500
|
$3,652,000 | 5.04% |
| Axsome Therapeutics Inc |
Opened
73,000
|
$3,257,000 | 4.50% |
| Chevron Corp. |
15.38%
22,500
|
$3,233,000 | 4.46% |
| ADTRAN Holdings Inc |
Opened
150,000
|
$2,937,000 | 4.05% |
| ADTRAN Holdings Inc |
Closed
150,000
|
$2,630,000 | |
| Envveno Med Corp |
No change
401,200
|
$2,520,000 | 3.48% |
| Clearside Biomedical Inc |
3.96%
2,197,480
|
$2,483,000 | 3.43% |
| IDEAYA Biosciences, Inc. |
Closed
173,500
|
$2,394,000 | |
| Laredo Petroleum Inc. |
164.84%
33,900
|
$2,131,000 | 2.94% |
| Arcturus Therapeutics Hldgs |
46.87%
120,400
|
$1,784,000 | 2.46% |
| Eiger BioPharmaceuticals Inc |
6.00%
235,000
|
$1,770,000 | 2.44% |
| Verona Pharma |
Opened
143,500
|
$1,467,000 | 2.02% |
| Energy Transfer L P |
No change
127,800
|
$1,410,000 | 1.95% |
| Diamondback Energy Inc |
162.50%
10,500
|
$1,265,000 | 1.75% |
| Myovant Sciences Ltd |
7.69%
60,000
|
$1,078,000 | 1.49% |
| INmune Bio, Inc. |
5.86%
151,100
|
$937,000 | 1.29% |
| Inhibikase Therapeutics, Inc. |
No change
937,500
|
$853,000 | 1.18% |
| Lantheus Holdings Inc |
Closed
12,900
|
$852,000 | |
| CF Industries Holdings Inc |
Closed
9,000
|
$772,000 | |
| Roku Inc |
141.07%
13,500
|
$761,000 | 1.05% |
| Maravai Lifesciences Holdings, Inc. |
Closed
24,500
|
$696,000 | |
| Affimed N.V. |
No change
308,800
|
$636,000 | 0.88% |
| Cambium Networks Corp |
Opened
34,400
|
$582,000 | 0.80% |
| TransMedics Group, Inc. |
Opened
12,500
|
$522,000 | 0.72% |
| Aurinia Pharmaceuticals Inc |
Closed
51,000
|
$513,000 | |
| Stratasys Ltd |
30.00%
35,000
|
$504,000 | 0.70% |
| Champions Oncology Inc |
No change
62,500
|
$469,000 | 0.65% |
| Icad Inc |
No change
205,000
|
$431,000 | 0.59% |
| Unity Software Inc. |
52.47%
12,500
|
$398,000 | 0.55% |
| Vista Oil Gas Sab De Cv Spon Ads Each Rep 1 Ord Shs Ser A |
No change
41,500
|
$391,000 | 0.54% |
| Denbury Inc. |
Opened
4,000
|
$345,000 | 0.48% |
| Zeta Global Holdings Corp. |
28.97%
51,500
|
$340,000 | 0.47% |
| Block Inc |
Opened
6,000
|
$330,000 | 0.46% |
| fuboTV Inc. |
27.27%
80,000
|
$284,000 | 0.39% |
| Qualtek Services Inc |
53.83%
138,500
|
$278,000 | 0.38% |
| Natera Inc |
Closed
7,000
|
$248,000 | |
| Oncocyte Corporation |
No change
330,000
|
$241,000 | 0.33% |
| Chesapeake Energy Corp. |
Opened
2,500
|
$236,000 | 0.33% |
| Rumble Inc |
Opened
19,100
|
$234,000 | 0.32% |
| Leap Therapeutics Inc |
No change
265,000
|
$233,000 | 0.32% |
| Oncternal Therapeutics, Inc. |
No change
210,000
|
$187,000 | 0.26% |
| Cardiff Oncology, Inc. |
No change
120,600
|
$186,000 | 0.26% |
| Surface Oncology Inc |
No change
170,500
|
$177,000 | 0.24% |
| Snowflake Inc. |
Opened
1,000
|
$170,000 | 0.23% |
| Aspira Womens Health Inc |
35.43%
417,123
|
$155,000 | 0.21% |
| DigitalOcean Holdings, Inc. |
60.00%
4,000
|
$145,000 | 0.20% |
| Cassava Sciences Inc |
Opened
3,400
|
$142,000 | 0.20% |
| Livent Corp |
Closed
6,000
|
$136,000 | |
| Marker Therapeutics, Inc. |
No change
354,400
|
$131,000 | 0.18% |
| Neoleukin Therapeutics, Inc. |
No change
199,000
|
$127,000 | 0.18% |
| Medicenna Therapeutics Corp. |
No change
149,070
|
$124,000 | 0.17% |
| Gritstone Bio Inc |
No change
47,500
|
$122,000 | 0.17% |
| Rhythm Pharmaceuticals Inc. |
Closed
27,500
|
$114,000 | |
| Amazon.com Inc. |
Closed
1,000
|
$106,000 | |
| Adaptimmune Therapeutics Plc |
No change
90,000
|
$97,000 | 0.13% |
| Draganfly Inc |
No change
135,000
|
$95,000 | 0.13% |
| Audacy Inc |
Closed
97,500
|
$92,000 | |
| Immatics N V |
Closed
10,300
|
$90,000 | |
| Cellectar Biosciences Inc |
Closed
217,500
|
$88,000 | |
| cbdMD Inc |
No change
147,000
|
$105,000 | 0.14% |
| Cellectar Biosciences Inc |
Opened
21,750
|
$73,000 | 0.10% |
| Enlivex Therapeutics Ltd. |
No change
15,000
|
$64,000 | 0.09% |
| Lottery.com Inc |
Closed
56,000
|
$63,000 | |
| Superior Drilling Prods Inc |
No change
80,000
|
$54,000 | 0.07% |
| Ampio Pharmaceuticals Inc |
Closed
291,500
|
$49,000 | |
| TRACON Pharmaceuticals Inc |
No change
28,500
|
$48,000 | 0.07% |
| Oyster Pt Pharma Inc |
No change
8,500
|
$48,000 | 0.07% |
| Cytosorbents Corp |
No change
35,000
|
$48,000 | 0.07% |
| Yalla Group Ltd |
No change
13,500
|
$44,000 | 0.06% |
| Helius Med Technologies Inc |
Closed
35,263
|
$42,000 | |
| Sio Gene Therapies Inc |
No change
146,500
|
$41,000 | 0.06% |
| PDS Biotechnology Corporation |
No change
12,000
|
$36,000 | 0.05% |
| SQZ Biotechnologies Co |
No change
16,000
|
$36,000 | 0.05% |
| Syros Pharmaceuticals Inc. |
Closed
35,000
|
$34,000 | |
| Cyteir Therapeutics Inc |
No change
15,000
|
$29,000 | 0.04% |
| Bioline Rx Ltd |
No change
27,500
|
$25,000 | 0.03% |
| Instil Bio Inc |
No change
5,000
|
$24,000 | 0.03% |
| Syros Pharmaceuticals Inc. |
Opened
3,499
|
$23,000 | 0.03% |
| Akerna Corp. |
Closed
128,000
|
$18,000 | |
| Mogo Inc |
Closed
19,491
|
$17,000 | |
| Aravive Inc |
No change
18,777
|
$15,000 | 0.02% |
| Airsculpt Technologies Inc |
No change
1,500
|
$10,000 | 0.01% |
| Transcode Therapeutics Inc |
No change
6,500
|
$7,000 | 0.01% |
| Genetron Holdings Limited |
No change
7,500
|
$6,000 | 0.01% |
| Atara Biotherapeutics Inc |
90.22%
900
|
$3,000 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 89 holdings | |||
Hedge funds similar to Act Capital Management
- Rizvi Traverse Management
- Roberts Capital Advisors
- Barnes Pettey Financial Advisors
- Oup Management Co
- Pension Partners
- Options Solutions
- Krs Capital Management
- Montchanin Asset Management
- Jcsd Capital
- James Reed Services
- Ibm Retirement Fund
- Qiming U.s. Ventures Management
- Mu Investments Co
- Kellett Schaffner Wealth Advisors